Sentante

Developing robotic system for endovascular procedures - Sentante a smart, sensory, teleoperated robot system which allows the procedure to be performed remotely, from a different room, thus protecting physicians from harmful X-rays and opening up tele-surgery possibilities. For more information, please visit our website: https://sentante.com/ Sentante is designed to be controlled in the same way as a manually performed endovascular procedure by using the conventional endovascular instruments guidewires and catheters. The proprietary patented technology is able to sense operators movements and provide close to natural haptic force feedback ensuring intuitive control of endovascular instruments while operating remotely, physicians can still...

Robotics,endovascular,surgery,and medtech

Sentante operates in the Medical equipment manufacturing industry.

Sentante's revenue is 11m - 100m

Sentante has 11 - 50 employees.